RCEL today
$16.20-$1.10 (-6.36%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourSymmetric Triangle
15 minBullish
5 minStrong Bearish
Daily trend turns down below $14.67
Key levels
Resistance$18.93
Resistance$16.90
Support$14.67
Support$12.70
Latest news & SEC filings
AnalystTD Cowen keeps Buy rating on AVITA Medical, lifts target to $22
AnalystMorgans lifts AVITA Medical rating one notch to Hold
AnalystBell Potter lifts its valuation on AVITA Medical to A$6.30
All RCEL news →About AVITA Medical
AVITA Medical is a wound care company addressing acute injuries. Its main product, RECELL, turns a small sample of the patient's skin into a cell suspension used for burn injuries and deep skin wounds, and it also sells the wound matrices PermeaDerm and Cohealyx. Customers include burn centers, trauma centers, and surgical facilities, mainly in the United States, with approvals in several other countries across Europe, Asia, and Australia.
Based on the company's 10-K filed Feb 12, 2026.
Nasdaq · Healthcare
AVITA Medical, Inc. (RCEL)
What Is the Price Target for RCEL?
SEPT Low Target
$6.00
SEPT Mid Target
$14.00
SEPT High Target
$15.00
Analyst Consensus
$14.00
Is RCEL a Buy or Sell Right Now?
Thesis
- •Revenue growing 11.4% YoY with STRONG trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RCEL.
Start Free Trial →Is RCEL Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
Analyst Consensus
Fair Value
$14.00
48
Moat Score
NARROW
2/9
Piotroski Score
-8.2
Altman Z-Score
What Is Smart Money Doing with RCEL?
Insider Signal
BUYING
9 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| O'Toole David D | officer | Buy | 2,000 | $8K | Jun 12, 2026 |
| Woody Joseph Fralin | director | Buy | 5,000 | $21K | Jun 9, 2026 |
| Woody Joseph Fralin | director | Buy | 5,200 | $21K | Jun 9, 2026 |
| Woody Joseph Fralin | director | Buy | 5,000 | $20K | Jun 3, 2026 |
| Woody Joseph Fralin | director | Buy | 5,000 | $21K | Jun 2, 2026 |
| Woody Joseph Fralin | director | Buy | 5,000 | $22K | Jun 1, 2026 |
| O'Toole David D | officer | Buy | 5,000 | $15K | May 29, 2026 |
| Vance Cary Guy | director officer | Buy | 5,000 | $15K | May 29, 2026 |
| O'Toole David D | officer | Buy | 2,000 | $9K | May 20, 2026 |
| O'Toole David D | officer | Buy | 2,000 | $8K | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RCEL Growth Story
Revenue YoY
11.4%
3yr Revenue CAGR
27.7%
EPS Growth YoY
27.2%
FCF Growth YoY
44.5%
Revenue Trend
STRONG
Dark Pool Trades for RCEL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RCEL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:15 | $16.20 | 1,600 | $$26K | SELL |
| 21:00:15 | $16.20 | 1,991 | $$32K | SELL |
| 20:46:27 | $16.32 | 2,447 | $$40K | SELL |
| 20:46:27 | $16.34 | 1,720 | $$28K | BUY |
| 19:47:01 | $16.70 | 2,500 | $$42K | BUY |
5 dark pool trades shown · $$168K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for AVITA Medical, Inc. (RCEL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RCEL — frequently asked questions
What is RCEL stock price today?
AVITA Medical, Inc. (RCEL) is at $16.20, down 6.36% (-$1.10) at the Nov 12, 2026 close.
Why is RCEL stock moving today?
Latest RCEL news — Nov 12, 2026: TD Cowen keeps Buy rating on AVITA Medical, lifts target to $22 · Nov 12, 2026: Morgans lifts AVITA Medical rating one notch to Hold
What is the RCEL price target?
The average analyst price target for RCEL is $14.00, ranging from $6 to $15, based on 3 analysts. Latest: BTIG maintains on Oct 12, 2026.
What do analysts rate RCEL?
Analyst ratings for RCEL: 2 Buy, 3 Hold, 0 Sell — consensus Hold.
Did RCEL beat earnings?
RCEL last reported on Aug 6, 2026: EPS -$0.25 vs -$0.29 expected — a beat of 14.6%.
Does RCEL pay a dividend?
RCEL does not currently pay a dividend.
What are RCEL support and resistance levels?
Support: $14.67, $12.70, $11.34. Resistance: $16.90, $18.93, $21.37.
What are insiders doing with RCEL?
Insider activity: BUYING, 9 buys and 0 sells in the last 90 days.
What is the latest news on RCEL?
Nov 12, 2026: TD Cowen keeps Buy rating on AVITA Medical, lifts target to $22 · Nov 12, 2026: Morgans lifts AVITA Medical rating one notch to Hold · Nov 10, 2026: Bell Potter lifts its valuation on AVITA Medical to A$6.30